康希诺生物(06185.HK):破伤风疫苗获国家药监局NDA批准

智通财经
Aug 20
【康希诺生物(06185.HK):破伤风疫苗获国家药监局NDA批准】智通财经APP讯,康希诺生物(06185.HK)发布公告,中国国家药品监督管理局(国家药监局)已批准本公司研发的吸附破伤风疫苗(破伤风疫苗)的新药上市申请(NDA)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10